Melipharm Overview

  • Founded
  • 2009

Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Angel

  • Investors
  • 1

Melipharm General Information

Description

Developer of sterile medical devices intended for the treatment of acute and chronic wounds. The company's sterile medical devices are a natural product that comes from the selection of honey essences whose anti-bacterial and healing properties have been validated by the researchers in the laboratory, enabling doctors to treat acute and chronic wounds based on selected monofloral honey.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Personal Products
Pharmaceuticals
Primary Office
  • 1 avenue d'Ester
  • Cedex 3
  • 87069 Limoges
  • France
+33 07 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Melipharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 01-Oct-2014 00000 Completed Generating Revenue
2. Angel (individual) 24-Jan-2012 00000 00000 00000 Completed Startup
1. Angel (individual) 27-Jul-2009 $140K $140K 00000 Completed Startup
To view Melipharm’s complete valuation and funding history, request access »

Melipharm Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 000.000000 000.00 000.00 00 000.00 00.00
Ordinary 0,000 000.000000 000.00 000.00 00 000.00 00.000
To view Melipharm’s complete cap table history, request access »

Melipharm Patents

Melipharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4032542-A1 Antimicrobial composition comprising a carbohydrate, glucose oxidase and zinc oxide Inactive 14-May-2014 0000000000 00
EP-3142687-A1 Antimicrobial composition comprising a carbohydrate, glucose oxydase and zinc oxide Inactive 14-May-2014 0000000000
FR-3020948-A1 Antimicrobial composition Active 14-May-2014 0000000000 0
FR-3020948-B1 Antimicrobial composition Active 14-May-2014 0000000000
US-20170072024-A1 Antimicrobial composition comprising a carbohydrate, glucose oxidase and zinc oxide Inactive 14-May-2014 A61K38/443
To view Melipharm’s complete patent history, request access »

Melipharm Executive Team (2)

Name Title Board Seat Contact Info
Celine Archer President
You’re viewing 1 of 2 executive team members. Get the full list »

Melipharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Melipharm Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Limousin Business Angels Angel Group Minority 000 0000 000000 0
To view Melipharm’s complete investors history, request access »